Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry and indicating a minor update in the page's version history.
    Difference
    0.1%
    Check dated 2026-05-15T04:53:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    New content sections Adverse Events and Outcome Measures (Results) were added to the study record history. The history also shows a Returned date of 2026-04-24 and a new Revision (v3.5.3) with QC status Has Not Concluded, replacing the prior Revision v3.5.2.
    Difference
    0.5%
    Check dated 2026-04-30T17:52:21.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.5.2 and removal of v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:07:55.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:59.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T14:38:28.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The funding lapse notice and the previous Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T01:46:21.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.